Cargando…

Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management

Venous thromboembolism (VTE) is a major health problem in patients with cancer. Cancer augments thrombosis and causes cancer-associated thrombosis (CAT) and vice versa thrombosis amplifies cancer progression, termed thrombosis-associated cancer (TAC). Risk factors that lead to CAT and TAC include ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamza, Marwa S., Mousa, Shaker A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476343/ https://www.ncbi.nlm.nih.gov/pubmed/32877229 http://dx.doi.org/10.1177/1076029620954282

Ejemplares similares

Current status and future directions in the management of chronic hepatitis C
por: Aman, Wosen, et al.
Publicado: (2012)

Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
por: Abdol Razak, Norbaini Binti, et al.
Publicado: (2018)

Therapeutics formulated to target cancer stem cells: Is it in our future?
por: Clayton, Stephanie, et al.
Publicado: (2011)

New Interfaces of Thyroid Hormone Actions With Blood Coagulation and Thrombosis
por: Davis, Paul J., et al.
Publicado: (2018)

Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
por: Lin, Yun, et al.
Publicado: (2010)

Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management
por: Wang, Tzu-Fei, et al.
Publicado: (2023)

Current primary open-angle glaucoma treatments and future directions
por: Beidoe, Gabriel, et al.
Publicado: (2012)

Management of Pancreatic Cancer and Its Microenvironment: Potential Impact of Nano-Targeting
por: Perko, Nardeen, et al.
Publicado: (2022)

Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
por: Falanga, Anna, et al.
Publicado: (2021)

Management of cancer-associated venous thrombosis
por: Er, Ozlem, et al.
Publicado: (2006)

Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management
por: Rofaiel, Sarah, et al.
Publicado: (2010)

Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
por: Salama, Lavinia, et al.
Publicado: (2020)

Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
por: Avery, Peter, et al.
Publicado: (2009)

Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence
por: Cimmino, Giovanni, et al.
Publicado: (2023)

Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic
por: Alsayegh, Faisal, et al.
Publicado: (2020)

Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities
por: Morales, Daniel E., et al.
Publicado: (2022)

Mechanisms of cancer-associated thrombosis
por: Mege, Diane, et al.
Publicado: (2019)

Mechanisms of cancer-associated thrombosis
por: Hisada, Yohei, et al.
Publicado: (2023)

Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis
por: Giuli, Lucia, et al.
Publicado: (2023)

Managing thrombosis in cancer patients
por: Wang, Tzu‐Fei, et al.
Publicado: (2018)

Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
por: El-Far, Ali H., et al.
Publicado: (2020)

Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects
por: Bharali, Dhruba J., et al.
Publicado: (2011)

The Role of Angiogenesis in Cancer Treatment
por: Rajabi, Mehdi, et al.
Publicado: (2017)

Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis
por: Plantureux, Léa, et al.
Publicado: (2018)

Mechanisms of thrombosis in ANCA-associated vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2021)

Thrombosis Risk Associated with Head and Neck Cancer: A Review
por: Haen, Pierre, et al.
Publicado: (2019)

Treatment and Prevention of Cancer-Associated Thrombosis in Frail Patients: Tailored Management
por: Scotté, Florian, et al.
Publicado: (2019)

Obstetric APS and thrombosis; modelling future risks
por: Spaanderman, M, et al.
Publicado: (2019)

Hepatitis C virus management: potential impact of nanotechnology
por: Elberry, Mostafa H., et al.
Publicado: (2017)

A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management
por: Safitri, Nisa, et al.
Publicado: (2021)

Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction
por: Tran, Khanh, et al.
Publicado: (2009)

Cancer-Associated Thrombosis: An Overview
por: Elyamany, Ghaleb, et al.
Publicado: (2014)

Cancer-associated thrombosis in Asia
por: Angchaisuksiri, Pantep
Publicado: (2016)

Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges
por: Frere, Corinne, et al.
Publicado: (2019)

Incidence, Therapy, and Bleeding Risk—Cancer- Associated Thrombosis in Patients with Glioblastoma
por: Muster, Viktoria, et al.
Publicado: (2020)

Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications
por: Mousa, Shaker A., et al.
Publicado: (2011)

Diabetes and skin cancers: Risk factors, molecular mechanisms and impact on prognosis
por: Dobrică, Elena-Codruta, et al.
Publicado: (2022)

A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection
por: Vahdat, Sahar
Publicado: (2022)

Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy
por: Srinivasan, Mathangi, et al.
Publicado: (2015)

Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
por: Szostakowska, Małgorzata, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rs6j438po9t4lqi92b6slc8jsq